저반응군의 체외수정에서 한 개의 배아 이식 시 임신에 영향을 주는 요인

Predictor of IVF Outcomes Following Single Embryo Transfer in Poor Responder Patients

  • 김혜옥 (관동대학교 의과대학 제일병원 산부인과 불임 및 생식내분비분과) ;
  • 김민지 (관동대학교 의과대학 제일병원 산부인과 불임 및 생식내분비분과) ;
  • 연명진 (관동대학교 의과대학 제일병원 산부인과 불임 및 생식내분비분과) ;
  • 차선화 (관동대학교 의과대학 제일병원 산부인과 불임 및 생식내분비분과) ;
  • 궁미경 (관동대학교 의과대학 제일병원 산부인과 불임 및 생식내분비분과) ;
  • 송인옥 (관동대학교 의과대학 제일병원 산부인과 불임 및 생식내분비분과)
  • Kim, Hye-Ok (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Kim, Min-Ji (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Yeon, Myeong-Jin (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Cha, Sun-Wha (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Koong, Mi-Kyoung (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine) ;
  • Song, In-Ok (Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine)
  • 발행 : 2008.09.30

초록

목 적: 난소기능이 저하된 저반응군 불임 여성에서 한 개의 배아를 이식할 때 임신율에 영향을 주는 요인에 대해 알아보고자 한다. 연구방법: 본원에서 1996년 6월부터 2006년 4월까지 시험관 시술을 받은 환자 중, basal FSH가 12 mIU/mL 이상, 획득된 난자가 4개 이하, hCG 투여일에 혈청 $E_2$가 500 pg/ml 미만인 저반응군 총 919주기에서 한 개의 배아만을 이식한 235주기를 대상으로 하였다. 여성의 연령, hCG 투여일에 혈청 $E_2$, basal FSH, 3일째 배아 이식 시 할구수, 과배란 유도 방법, 이식 횟수에 따른 임신율과 생존아 출생률을 비교하였으며, 통계학적인 방법은 Chi-square를 이용하여 p-value 0.05 이하인 경우를 유의하게 평가하였다. 결 과: 총 919주기 중 난자채취 취소율은 25.6% (235주기), 난자채취 실패율은 18.5% (170주기), 배아 이식 취소율은 14.0% (129주기)였다. 한 개의 배아를 이식한 군의 전체 임신율은 8.1% (19주기), 생존아 출생률은 4.7% (11주기)였고, 35세 미만의 여성에서 35세 이상의 여성보다 임신율과 생존아 출생률이 통계적으로 유의하게 높았다 (20% vs. 3.5% p<0.0001, 12.3% vs. 1.8%, p=0.002). hCG 투여일에 혈청 $E_2$, basal FSH, 3일째 배아 이식 시 할구수, 과배란 유도 방법에 따른 임신율과 생존아 출생률은 차이가 없었다. 이식 횟수에 따른 누적 임신율은 1회에 8.1%, 2회에 9.2%, 3회에 9.7%, 4회에 9.0%, 5회에 9.5%였다. 결 론: 저반응군의 체외수정에서 한 개의 배아를 이식할 때, 불임 여성의 연령이 35세 미만에서 임신율과 생존아출생률이 유의하게 증가함을 확인하였고, 이식 횟수에 따른 누적 임신율은 차이가 없었다. 이는 체외수정을 시도하려고 하는 난소기능 저하의 불임 여성에서 구체적인 상담 자료로 사용할 수 있겠다.

Objective: To evaluate predictor of IVF outcomes following single embryo transfer in patients with decreased ovarian reserve. Methods: A retrospective review was performed in 919 IVF cycles with elevated basal serum FSH (${\geq}12\;mIU/mL$), the number of retrieved oocytes ${\geq}4$ and serum $E_2$ concentration on hCG day <500 pg/ml between Jan. 1996 and Dec. 2006. Two hundred thirty five IVF cycles following single embryo transfer were included. Pregnancy rates and live birth rates was evaluated according to maternal age, serum $E_2$ on hCG day, basal FSH level, the number of blastomere on day 3 ET, stimulation protocol, the number of cycles of ET. Statistical analysis was used SPSS 12.0 program. Results: OPU cancellation rates were 25.6% (235 cycles), OPU failure rates were 18.5% (170 cycles), embryo transfer cancellation rates were 14.0% (129 cycles). Pregnancy rates following single embryo transfer was 8.1% (19 cycles) and live birth rates was 4.7% (11 cycles). Pregnancy rates and live birth rates of women under 35 years old was statistically higher than those of women above 35 years old (20% vs. 3.5% (p<0.0001), 12.3% vs. 1.8%, (p=0.002)). There was no difference in basal FSH, serum $E_2$ on hCG day, and the number of blastomere on ET, and stimulation protocol. Cumulative pregnancy rates according to the number of cycles of ET were $1^{st}$ 8.1%, $2^{nd}$ 9.2%, $3^{rd}$ 9.7%, $4^{th}$ 9.0%, and $5^{th}$ 9.5%. Conclusion: Pregnancy rates and live birth rates of IVF-ET cycles following single embryo transfer in patients with decreased ovarian reserve are statistically increased in women under 35 yrs old. There is no difference in cumulative pregnancy rates. These data may be helpful for counseling women with decreased ovarian reserve in attempting IVF with their own eggs or when choosing donor oocytes.

키워드

참고문헌

  1. Crosignani PG, Ragni G, Lombroso GC, Scarduelli C, de Lauretis L, Caccamo A, et al. IVF: induction of ovulation in poor responders. J Steroid Biochem 1989; 32: 171-3 https://doi.org/10.1016/0022-4731(89)90160-X
  2. Loutradis D, Vomvolaki E, Drakakis P. Poor responder protocols for in-vitro fertilization: options and results. Curr Opin Obstet Gynecol 2008; 20(4): 374-8 https://doi.org/10.1097/GCO.0b013e328305b9b8
  3. Ragni G, Somigliana E, Benedetti F, Paffoni A, Vegetti W, Restelli L, et al. Damage to ovarian reserve associated with laparoscopic excision of endometriomas: a quantitative rather than a qualitative injury. Am J Obstet Gynecol 2005; 193(6): 1908-14 https://doi.org/10.1016/j.ajog.2005.05.056
  4. Somigliana E, Ragni G, Benedetti F, Borroni R, Vegetti W, Crosignani PG. Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod 2003; 18(11): 2450-3 https://doi.org/10.1093/humrep/deg432
  5. Ho HY, Lee RK, Hwu YM, Lin MH, Su JT, Tsai YC. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet 2002; 19(11): 507-11 https://doi.org/10.1023/A:1020970417778
  6. Moomjy M, Mangieri R, Beltramone F, Cholst I, Veeck L, Rosenwaks Z. Shared oocyte donation: society's benefits. Fertil Steril 2000; 73(6): 1165-9 https://doi.org/10.1016/S0015-0282(00)00539-2
  7. Maxwell KN, Cholst IN, Rosenwaks Z. The incidence of both serious and minor complications in young women undergoing oocyte donation. Fertil Steril 2008 Feb 2. [Epub ahead of print]
  8. Check JH. In vitro fertilization is expensive: when should a couple be advised to stop trying with their own gametes and seek other options? Review of three cases. Clin Exp Obstet Gynecol 2008; 35(1): 5-9
  9. Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril 2007; 87: 749-56 https://doi.org/10.1016/j.fertnstert.2006.11.001
  10. Mahutte NG, Aydin Arici. Role of gonadotropin-releasing hormone antagonists in poor responders. Fertil Steril 2007; 87: 241-9 https://doi.org/10.1016/j.fertnstert.2006.07.1457
  11. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996; 65(5): 961-5 https://doi.org/10.1016/S0015-0282(16)58269-7
  12. Frattarelli JL, Hill MJ, McWilliams GD, Miller KA, Bergh PA, Scott RT. A luteal estradiol protocol for expected poor-responders improves embryo number and quality. Fertil Steril 2008; 89(5): 1118-22 https://doi.org/10.1016/j.fertnstert.2007.05.025
  13. Frattarelli JL, McWilliams GD, Hill MJ, Miller KA, Scott RT. Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertil Steril 2008; 89(5): 1113-7 https://doi.org/10.1016/j.fertnstert.2007.05.007
  14. Ubaldi F, Rienzi L, Baroni E, Ferrero S, Iacobelli M, Minasi MG, et al. Hopes and facts about mild ovarian stimulation. Reprod Biomed Online 2007; 14(6): 675-81 https://doi.org/10.1016/S1472-6483(10)60667-0
  15. Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008; 89(3): 546-53 https://doi.org/10.1016/j.fertnstert.2007.03.088
  16. Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Fertil Steril 2008; 89(1): 151-6 https://doi.org/10.1016/j.fertnstert.2007.02.013
  17. Frankfurter D, Dayal M, Dubey A, Peak D, Gindoff P. Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder. Fertil Steril 2007; 88(5): 1442-5 https://doi.org/10.1016/j.fertnstert.2007.01.022
  18. Balasch J, Fábregues F, Peñarrubia J, Carmona F, Casamitjana R, Creus M, et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod 2006; 21(7): 1884-93 https://doi.org/10.1093/humrep/del052
  19. Check JH. A 59-year-old woman gives birth to twins--when should a fertility specialist refuse treatment? Clin Exp Obstet Gynecol 2008; 35(2): 93-7
  20. Check JH, Katsoff B, Brasile D, Choe JK, Amui J. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women of more advanced reproductive age with elevated serum follicle stimulating hormone (FSH) levels. Clin Exp Obstet Gynecol 2008; 35(1): 13-5
  21. Check ML, Check JH, Kaplan H. Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review. Clin Exp Obstet Gynecol 2008; 35 (1): 13-5
  22. Katsoff B, Check JH. Successful pregnancy in a 45-year-old woman with elevated day 3 serum follicle stimulating hormone and a short follicular phase. Clin Exp Obstet Gynecol 2005; 32(2): 97-8 https://doi.org/10.1016/j.ogc.2004.10.003
  23. Check JH. Live delivery following transfer of a single frozen-thawed embryo derived from a 42-year-old woman with marked decreased oocyte reserve. Clin Exp Obstet Gynecol 2005; 32(1): 75-7
  24. Scott L, Alvero R, Leondires M, Miller B. The morphology of human pronuclear embryos is positively related to blastocyst development and implantation. Hum Reprod 2000; 15: 2394-403 https://doi.org/10.1093/humrep/15.11.2394
  25. Tesarik AM, Junca A, Hazout FX, Aubriot C, Nathan P, Cohen-Bacrie, et al. Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Hum Reprod 2000; 15: 1396-9 https://doi.org/10.1093/humrep/15.6.1396
  26. Shoukir Y, Campana A, Farley T, Sakkas D. Early cleavage of in vitro fertilized human embryos to the 2-cell stage: a novel indictor of embryo quality and viability. Hum Reprod 1997; 12: 1531-6 https://doi.org/10.1093/humrep/12.7.1531
  27. Ziebe S, Petersen K, Lindenberg S, Andersen AG, Garielsen A, Andersen AN. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod 1997; 12: 1545-9 https://doi.org/10.1093/humrep/12.7.1545
  28. Alikani M, Calderon G, Tomkin G, Garrisi J, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro. Hum Reprod 2000; 15: 2634-43 https://doi.org/10.1093/humrep/15.12.2634
  29. Hoover L, Baker A, Check JH, Lurie D, O'Shaughnessy A. Evaluation of a new embryo-grading system to predict pregnancy rates following in vitro fertilization. Gynecol Obstet Invest 1995; 40: 151-7 https://doi.org/10.1159/000292326
  30. Check JH, Wilson C, Summers-Chase D, Choe JK, Nazari A, Lurie D. Pregnancy rates (PRs) according to embryo cell number at time of embryo transfer (ET). Clin Exp Obstet Gynecol 2001; 28: 73-7
  31. Fisch JD, Rodriguez H, Ross R, Overby G, Sher G. The graduated embryo score (GES) predicts blastocyst formation and pregnancy rate from cleavage-stage embryos. Hum Reprod 2001; 16: 1970-5 https://doi.org/10.1093/humrep/16.9.1970
  32. Fisch JD, Sher G, Adamowicz M, Keskintepe L. The graduated embryo score predicts the outcome of assisted reproductive technologies better than a single day 3 evaluation and achieves results associate with blastocyst transfer from day 3 embryo transfer. Fertil Steril 2003; 80: 1352-8 https://doi.org/10.1016/j.fertnstert.2003.05.013